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Abstract
Background: Mild therapeutic hypothermia (MTH) is a recommended treatment of comatose patients 
after out-of-hospital cardiac arrest (OHCA). The aim of the study was to examine determinants of clini-
cal outcome in OHCA survivors treated with MTH and variables associated with MTH induction time.
Methods: Presented herein is an analysis of combined results from a retrospective and a prospec-
tive observational study which included 90 OHCA survivors treated with MTH from January 2010 to 
March 2018. Multivariate regression analysis was performed to determine variables associated with 
poor neurologic outcome (Cerebral Performance Category 3–5), mortality, and prolonged induction time.
Results: At hospital discharge, 59 (65.6%) patients were alive, of whom 36 (61%) had a good neuro-
logic outcome. Older patients (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.03–1.12) with lower 
Glasgow Coma Scale (GCS) (OR 0.49, 95% CI 0.30–0.80) were at higher risk of poor neurological out-
come. The predictors of in-hospital death included: older age (OR 1.08, 95% CI 1.02–1.13), lower GCS 
score (OR 0.47, 95% CI 0.25–0.85), presence of cardiogenic shock (OR 3.43, 95% CI 1.11–10.53), and 
higher doses of adrenaline (OR 1.27, 95% CI 1.04–1.56). Longer induction was associated with shorter 
cardio-pulmonary resuscitation (CPR) (unstandardized coefficient –3.95, 95% CI –7.09 to –0.81) and 
lower lactate level (unstandardized coefficient –18.55, 95% CI –36.10 to –1.01).
Conclusions: Unfavorable neurologic outcome in OHCA patients treated with MTH is associated 
with age and lower GCS score. Risk factors for in-hospital mortality include age, high-dose adrenaline 
administration, lower GCS score and presence of cardiogenic shock. CPR duration and lactate level 
were predictive of prolonged MTH induction time. (Cardiol J XXXX; XX, X: xx–xx)
Key words: mild therapeutic hypothermia, targeted temperature management,  
out-of-hospital cardiac arrest
Introduction
Out-of-hospital cardiac arrest (OHCA) is still 
burdened with high risk of death. Among those 
who experience OHCA only around 30% survive 
before hospital admission [1] and 10% until hos-
pital discharge [2]. The risk of OHCA occurrence 
is greater among the population of older men [3]. 
Even in survivors, brain damage leads to impaired 
neurological function and their ability to live an 
independent life is often limited [4]. Current guide-
lines recommend targeted temperature manage-
ment (TTM) for the treatment of comatose patients 
after OHCA [5, 6], however the results presented 
in the literature regarding cardiac arrest patients 
with non-shakable rhythms are inconclusive [7]. 
TTM is a term most commonly understood as 
maintenance of the body’s core temperature be-
tween 32°C and 36°C and therefore covers a wider 
range than mild therapeutic hypothermia (MTH), 
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defined as temperature control between 32°C and 
34°C. While favorable clinical outcome of MTH was 
proven in several clinical studies [8–10], the impact 
of maintaining patient temperatures at 34–36°C 
remains less clear. A randomized study by Nielsen 
et al. [11] suggests equivalent results in patients 
treated with TTM at 33°C and 36°C. Significant 
variability in clinical outcome among subjects 
treated with TTM raises questions regarding 
determinants of treatment success [12]. Despite 
the use of pre-specified programmed pattern of 
cooling, several studies reported that patients with 
poor neurological outcome had significantly shorter 
time required to achieve the target temperature 
(TT) than patients with good outcome [13–15]. 
These results raises the question about the causes 
of this phenomenon. Herein is hypothesized that 
a more severe ischemic insult may result in greater 
brain damage leading to impaired thermoregulatory 
control. According to this assumption, individuals 
with better post-OHCA neurologic function pre-
serve their thermoregulation ability, which in turn 
results in longer induction time of MTH. However, 
the question as to whether length of MTH induc-
tion is an indicator of brain damage severity and 
what are the predictors associated with prolonged 
MTH induction remains unanswered. 
Therefore, in this study possible determinants 
of clinical outcome in OHCA survivors treated with 
MTH were examined, including the induction time. 
Variables associated with the duration of MTH 
induction were also evaluated. 
Methods
Study design and TTM protocol
This study combines results of a retrospective 
observational single-center analysis performed at 
the Department of Cardiology and Internal Medi-
cine of the University Hospital No. 1 in Bydgoszcz, 
Poland from January 2010 to December 2016 and 
a prospective, observational, multicenter study 
[16] performed from January 2017 to March 2018 
including OHCA survivors treated with MTH. The 
study comprised all consecutive adult subjects 
treated with MTH (using invasive intravascular 
cooling with TT of 33°C) for non-traumatic OHCA 
regardless of initial rhythm, who achieved a return 
of spontaneous circulation (ROSC). The Utstein-
style guidelines for reporting OHCA were imple-
mented in the study [17].
According to local protocol, patients were con-
sidered for MTH if they remained comatose after 
return of ROSC. Cooling was initiated as soon as 
possible with ice packs, intravenous administra-
tion of cold normal saline (0.9% solution of sodium 
chloride at the temperature of 4°C), and Intravas-
cular Temperature Management™ CoolGard 3000® 
(Zoll Circulation Inc. USA). MTH was considered 
effective when patient core temperature decreased 
below 34°C, with TT of 33.0 ± 0.2°C, and was main-
tained for at least 12 h with an optimal duration of 
24 h. The rewarming phase was conducted in an 
actively controlled manner at a rate of 0.3°C per 
hour. Urine bladder temperature measurements 
were used to automatically guide changes in patient 
core temperature. All patients were mechanically 
ventilated, sedated with continuous intravenous 
infusion of propofol and fentanyl and were treated 
according to current European Society of Cardiolo-
gy guidelines. More detailed information regarding 
MTH protocol has been previously described [10].
The study was conducted in accordance with 
the Declaration of Helsinki and Good Clinical 
Practice guidelines and was approved by the Ethics 
Committee of The Nicolaus Copernicus Univer-
sity in Torun, Collegium Medicum in Bydgoszcz 
(approval reference number KB 615/2015). The 
prospective part of this study is a sub-study of the 
Mild Therapeutic Hypothermia for Patients With 
Acute Coronary Syndrome and Cardiac Arrest 
Treated With Percutaneous Coronary Intervention 
(UNICORN) study (ClinicalTrials.gov Identifier: 
NCT02611934), which was supported by “Diamen-
towy Grant” financed by the Ministry of Science 
and Higher Education of the Republic of Poland 
from research funds for the years 2015–2018.
Data collection
Data were obtained from hospital records 
and included: age, sex, comorbidities, first moni-
tored rhythm, bystander basic life support (BLS), 
total dose of adrenaline (epinephrine) used by 
emergency medical service (EMS) during cardio-
pulmonary resuscitation (CPR), etiology of cardiac 
arrest, Glasgow Coma Scale (GCS) score on admis-
sion, blood pH on admission, blood lactate level 
on admission, left ventricular ejection fraction 
on admission, presence of cardiogenic shock, and 
initial temperature measured in the urinary bladder 
(recorded at the initiation of intravascular cooling). 
Time intervals used for the analysis included: time 
in cardiac arrest (time from the onset of OHCA to 
ROSC), CPR duration (time from the beginning of 
CPR by EMS to ROSC), pre-induction (time from 
ROSC to initiation of intravascular cooling), induc-
tion (time from initiation of intravascular cooling to 
arrival at TT of 33.0 ± 0.2°C), maintenance (time 
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from arrival at TT to initiation of active rewarm-
ing). Neurologic outcome was assessed using the 
Glasgow–Pittsburgh Cerebral Performance Cat-
egories (CPC) at hospital discharge and recorded 
as CPC 1 (good performance), CPC 2 (moderate 
disability), CPC 3 (severe disability), CPC 4 (veg-
etative state), or CPC 5 (brain death or death) [18]. 
Good neurological outcome was defined as CPC 
1–2 and poor neurologic outcome was CPC 3–5 at 
the time of hospital discharge. 
Statistical analysis
Continuous variables were presented as 
means with standard deviation or medians with 
interquartile range according to the distribution. 
Categorical variables were described as frequen-
cies and percentages. Normality of the distribution 
was examined with the Shapiro-Wilk test. The 
Student T-test or Mann-Whitney test were used 
for comparison of continuous variables based on 
distribution normality. Categorical variables were 
compared using the c2 or Fisher’s exact test, as 
appropriate. Univariate logistic regression analysis 
was performed to determine variables associated 
with poor neurologic outcome and in-hospital 
mortality. In order to identify variables affecting 
MTH induction time, univariate linear regression 
analysis was conducted. All variables significant at 
p ≤ 0.1 in the univariate analysis were entered into 
multivariate regression models. Stepwise regres-
sion with backward elimination was performed 
to find the best possible fitting of each model. All 
statistical analysis was performed with IBM SPSS 
Statistics version 23. A two-sided significance level 
of p < 0.05 was applied for statistical significance.
Results
Population characteristics  
and final outcome
A total of 114 adult cardiac arrest patients 
were treated with MTH during the study period. 
Twenty-four patients were excluded from analysis 
(Fig. 1) and data on the remaining 90 patients were 
further investigated. At hospital discharge, 59 
(65.56%) patients were alive, of whom 36 (61.02%) 
had a good neurologic outcome. Their clinical 
characteristics stratified by outcomes is shown in 
Table 1. The study group consisted mainly of men 
(n = 72, 80%). Mean age was 61.8 ± 12.5 years. 
In the majority of patients (n = 79, 87.8%), the 
initial recorded rhythm was shockable. Patients 
with good neurologic outcome were younger than 
those with poor outcome (56.4 ± 12.1 vs. 65.3 ± 
11.5, p = 0.001), had a higher incidence of shock-
able initial rhythm (100% vs. 79.6%, p = 0.003) and 
a higher GCS score on admission (4.0 [4.0–5.0] vs. 
3.5 [3.0– 4.0], p = 0.004).
Survivors, as compared with non-survivors, 
were younger (59.3 ± 12.1 vs. 66.5 ± 12.0, 
p = 0.009), more likely to have shockable initial 
rhythm (93.2% vs. 77.4%, p = 0.04) and less likely 
to present with cardiogenic shock (45.8% vs. 71.0%, 
p = 0.02). They also required smaller amounts of 
adrenaline during CPR (2.0 mg [1.0–5.0] vs. 4.0 mg 
[2.75–7.0], p = 0.006) and had a higher GCS 
score on admission (4.0 [3.0–5.0] vs. 3.0 [3.0–4.0], 
p = 0.004] (Table 1).
According to the univariate analysis, lower 
admission GCS score, older age and shorter MTH 
induction time were associated with poor neuro-
Figure 1. Numbers of patients initially screened, those excluded from the study and finally those who were included 
for analysis; GCS — Glasgow Coma Scale; IHCA — in-hospital cardiac arrest; MTH — mild therapeutic hypothermia.
Adult cardiac arrest patients treated with MTH during the study period
(n = 114)
Patients included for the analysis
(n = 90)
Excluded (n = 24):
• Patients with IHCA (n = 2)
• Initial temperature < 34°C (n = 2)
• Failed to achieve a target temperature (n = 5)
• GCS on admission > 6 (n = 4)
• Insufcient data regarding time variables (n = 11)
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logical outcome (CPC 3–5) at hospital discharge 
(Table 2). As a result of stepwise regression 
with backward elimination, two parameters — 
lactate level and MTH induction time — were 
excluded from the equation. The best fitted 
multiple regression model revealed that older 
patients (odds ratio [OR] 1.07, 95% confidence 
interval [CI] 1.03–1.12, p = 0.001) and those with 
a lower GCS score on admission (OR 0.49, 95% 
CI 0.30–0.80, p = 0.004) were at higher risk of 
poor neurological outcome.
Analogous analysis was conducted to deter-
mine risk factors of non-survival. In the univariate 
analysis, older age, higher adrenaline dosage during 
CPR, lower admission GCS score and presence 
of cardiogenic shock were associated with higher 
in-hospital mortality (Table 2). For multivariate 
analysis two new variables were added, i.e. CPR 
duration and bystander BLS. Eventually, stepwise 
regression revealed older age (OR 1.08, 95% CI 
1.02–1.13, p = 0.006), lower GCS score (OR 0.47, 
95% CI 0.25–0.85, p = 0.01), presence of cardio-
genic shock (OR 3.43, 95% CI 1.11–10.53, p = 
0.03), and higher doses of adrenaline during CPR 
(OR 1.27, 95% CI 1.04–1.56, p = 0.02) to be risk 
factors of in-hospital death. 
Determinants of the duration  
of MTH induction
Patients who recovered with a CPC of 1 or 2, had 
a significantly longer median induction time than 
patients with a CPC of 3–5 (325.0 min [230.0–615.0] 
vs. 260.0 min [180.0–360.0], p = 0.04; Table 3). 
According to univariate analysis, lower lactate 
level, higher GCS score on admission, higher initial 
body temperature, shorter time in cardiac arrest 
and shorter CPR duration were significantly associ-
ated with the duration of MTH induction (Table 4). 
As a potential confounder, initial temperature was 
excluded from further analysis. According to multi-
variate analysis, longer duration of MTH induction 
was independently associated with shorter CPR 
duration [unstandardized coefficient –3.95, 95% CI 
–7.09 to –0.81, p = 0.01) and lower lactate level 
(unstandardized coefficient –18.55, 95% CI –36.10 
to –1.01, p = 0.04).
Discussion
No differences were found regarding MTH 
induction time in terms of OHCA survival, however 
patients with poor neurologic outcome had signifi-
cantly shorter MTH induction time than patients 
with a good outcome. Older age and lower GCS 
score on admission were also identified as inde-
pendent predictors of worse neurologic outcome as 
well as older age, higher adrenaline dosage during 
CPR, lower baseline GCS score and presence of 
cardiogenic shock as independent risk factors of 
mortality. CPR duration and lactate concentration 
were independently associated with the duration 
of MTH induction. 
Previous studies delivered inconsistent re-
sults regarding the relationship between MTH 
induction time and neurologic outcome. Nielsen 
et al. [19] reported that neither time to initiation 
of TTM, time to achieve TT, duration of TTM nor 
rewarming time were associated with neurologic 
outcome. An analysis of 588 patients conducted 
by Haugk et al. [13] indicated that patients with 
favorable outcome had both longer — time from 
ROSC to TT as well as induction time, with no 
difference in time from ROSC to initiation of cool-
ing. They also performed a multivariate regres-
sion analysis and found 86% higher odds of a good 
neurologic outcome with an increase in each tertile 
(< 120 min, 120–220 min, and > 220 min) of time to 
TT (adjusted OR 1.86, p = 0.04). The median time 
needed to achieve TT, despite numerical differ-
ence, was not associated with overall survival (202 
min for survivors vs. 158 min for non-survivors, 
p = 0.57). Several procedure-related differences 
between the studies and within particular studies 
should be underlined. In the study by Haugk et al. 
[13], TT was defined as less than 34°C and differ-
ent cooling methods including endovascular, head 
cooling, surface (ice, water, air), nasopharyngeal, 
intravenous, and mixed were applied. Perman 
et al. [14] analyzed 321 patients from various 
centers and categorized them by induction time 
(< 120 min, 120–300 min, > 300 min). The authors 
reported that age, shockable initial rhythm, time in 
cardiac arrest and induction time > 300 min were 
associated with a higher probability of a favorable 
neurologic outcome. In contrast to this, other 
publications showed rapid TT achievement to be 
associated with better neurologic results [20–23]. 
However, all those studies defined time to TT as 
the period from the onset of cardiac arrest to ar-
rival at a temperature of 33°C or < 34°C, therefore 
it was equivalent to three different time intervals 
used in the current study (time in cardiac arrest, 
pre-induction and induction). In each of these time 
periods patients are affected by various conditions 
potentially determining outcome, thus we believe 
that the analysis should be conducted separately 
for each of these time intervals. Shorter time in 
cardiac arrest [19, 24] and sooner initiation of 
www.cardiologyjournal.org 5
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MTH [25] were associated with better neurologic 
outcome. Lee et al. [15] analyzed 515 patients 
treated with MTH in terms of time intervals and 
neurologic outcome. Despite a significant differ-
ence in the induction time between the groups 
with favorable and unfavorable outcome and no 
difference in the pre-induction time, regression 
analysis revealed the opposite results. No asso-
ciation between induction time and outcome were 
found while elongation of pre-induction by each 
30 min increased the odds for poor outcome by 
11%. In the present study, induction time was also 
found to be significantly longer in patients with 
good neurologic outcome when compared with the 
poor outcome group. Subsequent univariate analy-
sis revealed an association between MTH induction 
time and neurological outcome, however, similar to 
the results presented by Lee et al. [15], the finding 
was not confirmed in the multivariate model. Un-
like the analysis by Haugk et al. [13] and Perman 
et al. [14], the induction time was not categorized 
to avoid a possible bias resulting from switching 
from a continuous to categorical variable. In the 
current study, older age and lower GCS score on 
admission were the only independent risk factors 
of poor neurologic outcome, these observations 
are consistent with previous studies [15, 19]. The 
phenomenon of shorter induction time in patients 
with unfavorable outcome was suspected to be a 
result of more severe initial brain injury, impaired 
thermoregulation, and greater vulnerability to 
cooling [14]. A study evaluating heat genera-
tion in patients treated with MTH after cardiac 
arrest revealed an association between greater 
heat production and better baseline health status, 
reduced ischemic injury and improved neurologic 
outcome [26]. A study published by Leão et al. [27] 
showed that, apart from shorter induction time, 
patients with unfavorable neurologic outcome had 
a higher incidence of hypoxic-ischemic brain injury 
on magnetic resonance imagining and a higher 
concentration of neuron specific enolase. The 
present results are consistent with these studies 
[14, 15, 19, 26, 27] and might indirectly support the 
Table 4. Univariate and multivariate regression analysis for mild therapeutic hypothermia (MTH)  
induction time.
Univariate analysis Multivariable analysis 
Unstandardised  
coefficient (95% CI)
P Unstandardised  
coefficient (95% CI)
P
Age (n = 90) –2.49 (–6.39 to 1.42) 0.21 – –
Male (n = 90) –7.65 (–129.93 to 114.63) 0.9 – –
Initial shockable rhythm (n = 90) 81,27 (–69.47 to 232,0) 0.29 – –
Bystender BLS (n = 88) 31.92 (–67.54 to 131.38) 0.53 – –
Adrenaline (n = 83) –9.362 (–26.98 to 8.26) 0.29 – –
Ischemic etiology (n = 90) –13.97 (–148.9 to 120.967) 0.62 – –
pH (n = 90) 124.76 (–319.6 to 569.13) 0.58 – –
Lactate (n = 72) –20.38 (–38.56 to –2.2) 0.03 –16.2 (–34.49 to 2.1) 0.08
EF (n = 87) 0.964 (–4.307 to 6.235) 0.72 – –
GCS on admission (n = 90) 47.87 (1.63 to 94.11) 0.04 25.77 (–27.31 to 78.87) 0.34
Cardiogenic shock (n = 90) –40.06 (–137.89–57.78) 0.42 – –
Initial temperature (n = 72) 116.75 (73.17 to 160.33) <0.001 – –
Hypertension (n = 90) 52.69 (–45.36 to 150.73) 0.29 – –
Diabetes mellitus (n = 90) 85.84 (–17.14 to 188.82) 0.101 – –
Previous stroke (n = 90) –116.04 (–310.5 to 78.43) 0.24 – –
Previous ACS (n = 90) 47.31 (–60.12 to 78.43) 0.38 – –
Time in cardiac arrest (n = 90) –3.35 (–6.25 to –0.45) 0.02 3.31 (–4.48 to 11.01) 0.4
CPR duration (n = 90) –4.23 (–7.05 to –1.4) 0.004 –6.75 (–14.62 to 1.11) 0.09
Pre-induction time (n = 79) 0.17 (–0.42 to 0.762) 0.56 – –
ACS — acute coronary syndrome; BLS — basic life support; CI — confidence interval; CPR — cardio-pulmonary resuscitation; EF — ejection 
fraction; GCS — Glasgow Coma Scale
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hypothesis that shorter induction time in patients 
with unfavorable neurological outcome is related 
to more severe brain injury, since the initial neu-
rologic condition reflected by GCS on admission 
was a strong outcome predictor. Furthermore, an 
association between longer MTH induction time 
and higher GCS score was found in univariate 
analysis, however results were not confirmed in 
the multivariate model. The differences between 
the studies regarding time intervals could result 
from the implementation of various definitions, 
different methods of cooling [28] and temperature 
measurement [29], and heterogeneity of the study 
populations (inclusion of patients regardless of the 
etiology and place of cardiac arrest or the type of 
the initial rhythm).
There were no differences in time intervals 
between survivors and non-survivors in the present 
study. Similar results were presented by Haugk et al. 
[13]. The current study found that older age, higher 
doses of adrenaline during CPR, lower GCS score on 
admission and presence of cardiogenic shock were 
predictors of in-hospital mortality. Lee et al. [15] also 
reported lower initial GCS scores along with non-
shockable rhythm, longer time in cardiac arrest and 
a higher Sequential Organ Failure Assessment (SOFA) 
score were independent risk factors for mortality, 
while no association was found between other time 
variables (pre-induction and induction) and odds for 
survival. In contrast to previous results, Leão et al. 
[27] showed a correlation between higher mortality at 
6 months after cardiac arrest and shorter time to TT.
Addressing the multiple inconsistencies re-
garding time intervals in TTM and particularly the 
MTH induction time, the predictors were deter-
mined for delayed achievement of TT. In univariate 
regression analysis, longer MTH induction time 
was associated with lower lactate level, higher 
GCS score on admission, shorter time in cardiac 
arrest, and shorter CPR duration. According to the 
multivariate analysis, only shorter CPR duration 
and lower lactate level on admission were associ-
ated with prolonged induction time. The role of 
initial temperature in patients treated with MTH 
was raised in some previous studies, linking lower 
initial temperature with in-hospital [30] and long-
term [31] mortality. This parameter however, was 
excluded from analysis as a potential confounder. 
Limitations of the study
One of the main limitations of the present 
study is its partly retrospective and observational 
nature. Furthermore, only a relatively small group 
of patients were analyzed. Another limitation was 
the difficulty in precisely determining all essential 
time points. 
Conclusions
Favorable neurologic outcome (CPC 1–2) in 
OHCA patients treated with MTH is associated 
with younger age and higher GCS score upon ad-
mission. The risk factors for increased in-hospital 
mortality in this population included older age, 
higher doses of adrenaline during CPR, lower GCS 
score on admission and presence of cardiogenic 
shock. Neither the induction nor pre-induction time 
was an independent risk factor for neurologic out-
come or overall survival. CPR duration and lactate 
level on admission were predictors for prolonged 
induction time. 
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